Effects of Pentoxiphylline on Left Ventricular Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Pentoxifylline (Primary)
- Indications Heart failure
- Focus Biomarker; Therapeutic Use
- Acronyms PENT-CHF
- 10 Jun 2017 Biomarkers information updated
- 28 Aug 2013 Planned end date changed from 1 Jul 2012 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 25 Apr 2011 New trial record